In this study, we assessed the expression patterns and clinical significance of ICOS in patients with NSCLC from the mRNA, protein, and serological aspects, as well as their correlation with PD-L1, tumor immune infiltrating cells and prognostic significance. The gene discussed is CD274; the disease is non-small cell lung carcinoma.